<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1688-1249</journal-id>
<journal-title><![CDATA[Archivos de Pediatría del Uruguay]]></journal-title>
<abbrev-journal-title><![CDATA[Arch. Pediatr. Urug.]]></abbrev-journal-title>
<issn>1688-1249</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Uruguaya de Pediatría]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1688-12492022000301210</article-id>
<article-id pub-id-type="doi">10.31134/ap.93.s1.5</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Tuberculosis en tiempos de COVID-19. Situación de la tuberculosis pediátrica en Uruguay en 2020]]></article-title>
<article-title xml:lang="en"><![CDATA[Tuberculosis in times of COVID-19. Pediatric tuberculosis in Uruguay in 2020]]></article-title>
<article-title xml:lang="pt"><![CDATA[Tuberculose em tempos de COVID-19. Situação da tuberculose pediátrica no Uruguai em 2020]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Amaya]]></surname>
<given-names><![CDATA[Gabriela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Moreira]]></surname>
<given-names><![CDATA[Valeria]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sisto]]></surname>
<given-names><![CDATA[Gabriela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,CHLA-EP Programa Nacional de Tuberculosis ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af2">
<institution><![CDATA[,CHLA-EP  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2022</year>
</pub-date>
<volume>93</volume>
<numero>nspe1</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S1688-12492022000301210&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S1688-12492022000301210&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S1688-12492022000301210&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción: la Organización Mundial de la Salud (OMS) alertó sobre el riesgo de descuidar acciones de control de la tuberculosis (TB) durante la pandemia de COVID-19.  Objetivos:  describir la situación de la TB en menores de 15 años en Uruguay en 2020, y compararla con 2019. Describir estrategias del Programa Nacional de Tuberculosis (PNT) para mitigar el impacto de la pandemia de COVID-19.  Metodología:  Estudio descriptivo, retrospectivo de menores de 15 años con TB en Uruguay entre 1/1/2020 y 31/12/2020. Datos patronímicos, diagnóstico clínico y bacteriológico, tratamiento y estudio de contactos; indicadores epidemiológicos de 2019. Se calculó tasa de incidencia, frecuencias y porcentajes. Se seleccionaron estrategias del PNT dirigidas o que impactan directamente en la atención pediátrica.  Resultados: en 2020, se registraron 61 casos de TB en menores de 15 años. Tasa de incidencia 8,8/100.000. Presentaron TB pediátrica 6,3% del total de casos (61/968), y en 2019 3,9% (42/1057). Formas pulmonares 84% y extrapulmonares 16%. Confirmación bacteriológica: 25%. No hubo fallecidos en 2020 y hubo uno en 2019. Contactos: en 2020 disminuyó 11% la notificación; se estudió al 86%, se indicó quimioprofilaxis al 73%. Aumento significativo de contactos en menores 15 años enfermos (2,4% 2019 y 5% 2020). Estrategias del PNT: 1) Diagnóstico: uso de GeneXpert Ultra; 2) Tratamiento: supervisión por video (VOT); 3) Contactos: se priorizó a menores de 15 años adecuando protocolo de estudio.  Conclusiones:  en 2020 se mantuvieron las acciones de control de la TB en la población pediátrica. Aumentó la incidencia de TB en menores de 15 años. Los niños y adolescentes fueron priorizados en el diagnóstico (técnicas más sensibles) y estudio de contactos.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Summary:  Introduction: the WHO warned about the risk of neglecting tuberculosis (TB) control actions during the COVID-19 pandemic.  Objectives: describe the TB situation in children &lt;15 years of age in Uruguay in 2020, and compare it with 2019. Describe strategies of the National Tuberculosis Program (NTP) to mitigate the impact of the COVID 19 pandemic.  Material and methods: descriptive, retrospective study of children &lt;15 years of age with TB in Uruguay 1/1/2020 - 12/31/2020. Patronymic data, clinical and bacteriological diagnosis, treatment and study of contacts; epidemiological indicators of 2019. Incidence rate, frequency and percentages were calculated. NTP strategies aimed at or directly impacting pediatric care were selected.  Results: in 2020, 61 cases of TB in children &lt; 15 years. Incidence rate 8.8/100,000. Pediatric TB 6.3% of total cases (61/968), and in 2019 3.9% (42/1057). Pulmonary forms 84% and extrapulmonary 16%. Bacteriological confirmation: 25%. No deaths in 2020 and 1 in 2019. Contacts: in 2020 the notification decreased by 11%; 86% were studied, 73% chemoprophylaxis. Significant increase in infected contacts &lt; 15(2.4% 2019 and 5% 2020). NTP strategies: 1- Diagnosis: use of GeneXpert Ultra; 2- Treatment: video surveillance (VOT); 3- Contacts: children of &lt;15 years were prioritized, adapting the study protocol.  Conclusions: in 2020, the TB control actions were maintained in the pediatric population. The incidence of TB increased in children &lt;15 years of age. Children and adolescents were prioritized in diagnosis (more sensitive techniques) and contact studies.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo:  Introdução:  a OMS alertou sobre o risco de negligenciar as ações de controle da tuberculose (TB) durante a pandemia de COVID-19.  Objetivos: descrever a situação da TB em &lt;15 anos no Uruguai 2020 e comparar com 2019. Descrever as estratégias do Programa Nacional de Tuberculose (PNT) para mitigar o impacto da pandemia de COVID-19.  Metodologia: estudo descritivo retrospectivo de &lt;15 anos com TB no Uruguai 01/01/2020 - 31/12/2020. Dados patronímicos, diagnóstico clínico e bacteriológico, tratamento e estudo de contatos; indicadores epidemiológicos de 2019. Calculou-se a taxa de incidência, frequência e percentuais. Estratégias de PNT destinadas ou impactando diretamente os cuidados pediátricos foram selecionadas  Resultados: em 2020, 61 casos de TB em crianças &lt;15 anos. Taxa de incidência 8,8/100.000. TB pediátrica 6,3% do total de casos (61/968), e em 2019 3,9% (42/1057). Formas pulmonares 84% e extrapulmonares 16%. Confirmação bacteriológica: 25%. Não houve falecidos em 2020 e 1 em 2019. Contatos: em 2020 a notificação diminuiu 11%; 86% foram estudados, 73% quimioprofilaxia. Aumento significativo de contatos infetados &lt; 15 pacientes (2,4% 2019 e 5% 2020). Estratégias de NTP: 1- Diagnóstico: uso do GeneXpert Ultra; 2- Tratamento: supervisão por vídeo (VOT); 3- Contatos: &lt;15 anos foram priorizados, adaptando o protocolo do estudo.  Conclusões: em 2020, as ações de controle da TB foram mantidas na população pediátrica. A incidência de TB aumentou em &lt;15 anos. Crianças e adolescentes foram priorizados no diagnóstico (técnicas mais sensíveis) e no estudo de contatos.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Tuberculosis]]></kwd>
<kwd lng="es"><![CDATA[SARS-CoV-2]]></kwd>
<kwd lng="es"><![CDATA[Niño]]></kwd>
<kwd lng="es"><![CDATA[COVID-19]]></kwd>
<kwd lng="en"><![CDATA[Tuberculosis]]></kwd>
<kwd lng="en"><![CDATA[SARS-CoV-2]]></kwd>
<kwd lng="en"><![CDATA[Child]]></kwd>
<kwd lng="en"><![CDATA[COVID-19]]></kwd>
<kwd lng="pt"><![CDATA[Tuberculose]]></kwd>
<kwd lng="pt"><![CDATA[SARS-CoV-2]]></kwd>
<kwd lng="pt"><![CDATA[Criança]]></kwd>
<kwd lng="pt"><![CDATA[COVID-19]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[Global tuberculosis report 2021]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<collab>Comisión Honoraria para la Lucha Antituberculosa y Enfermedades Prevalentes</collab>
<source><![CDATA[Programa Nacional de Tuberculosis. Informe nacional de la situación de la tuberculosis en Uruguay 2020]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[CHLA-EP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[World Health Organization (WHO) Information note: tuberculosis and COVID-19]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[Maintaining essential health services: operational guidance for the COVID-19 context, interim guidance, 1 june 2020]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[WHO information note: COVID-19: considerations for tuberculosis (TB) care]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Glaziou]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predicted impact of the COVID-19 pandemic on global tuberculosis deaths in 2020]]></article-title>
<source><![CDATA[Med Rxiv]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hogan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Jewell]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Sherrard]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Vesga]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Watson]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Whittaker]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries a modelling study]]></article-title>
<source><![CDATA[Lancet Glob Health]]></source>
<year>2020</year>
<volume>8</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>e1132-41</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McQuaid]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[McCreesh]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Read]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sumner]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Houben]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[White]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The potential impact of COVID-19-related disruption on tuberculosis burden]]></article-title>
<source><![CDATA[Eur Respir J]]></source>
<year>2020</year>
<volume>56</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>2001718</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martinez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Cords]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Horsburgh]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Andrews]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The risk of tuberculosis in children after close exposure a systematic review and individual-participant meta-analysis]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2020</year>
<volume>395</volume>
<numero>10228</numero>
<issue>10228</issue>
<page-range>973-84</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<collab>Sixty-seventh World Health Assembly</collab>
<source><![CDATA[Global strategy and targets for tuberculosis prevention, care and control after 2015 (Resolution WHA67.1, Agenda item 12.1)]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<collab>Naciones Unidas</collab>
<collab>Departamento de Asuntos Económicos y Sociales</collab>
<source><![CDATA[Desarrollo Sostenible. Los 17 objetivos]]></source>
<year>2021</year>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[UN]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<collab>Comisión Honoraria para la Lucha Antituberculosa y Enfermedades Prevalentes</collab>
<article-title xml:lang=""><![CDATA[Capítulo 6: control de contactos]]></article-title>
<collab>Comisión Honoraria para la Lucha Antituberculosa y Enfermedades Prevalentes</collab>
<collab>Ministerio de Salud Pública</collab>
<collab>Universidad de la República</collab>
<collab>Facultad de Medicina</collab>
<collab>Cátedra de Enfermedades Infecciosas</collab>
<collab>Cátedra de Neumología</collab>
<source><![CDATA[Guía nacional para el manejo de la tuberculosis]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[CHLA-EP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Buonsenso]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Iodice]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Sorba]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Goletti]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COVID-19 effects on tuberculosis care in Sierra Leone]]></article-title>
<source><![CDATA[Pulmonology]]></source>
<year>2021</year>
<volume>27</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>67-9</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Adewole]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impact of COVID-19 on TB care experiences of a treatment centre in Nigeria]]></article-title>
<source><![CDATA[Int J Tuberc Lung Dis]]></source>
<year>2020</year>
<volume>24</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>981-2</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[de Souza]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Coutinho]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Magalhães]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Carmo]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impact of COVID-19 on TB diagnosis in Northeastern Brazil]]></article-title>
<source><![CDATA[Int J Tuberc Lung Dis]]></source>
<year>2020</year>
<volume>24</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1220-2</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Xia]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Pan]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Yuan]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impact of the COVID-19 pandemic on the detection of TB in Shanghai, China]]></article-title>
<source><![CDATA[Int J Tuberc Lung Dis]]></source>
<year>2020</year>
<volume>24</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1122-4</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amaya]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Contrera]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Arrieta]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Montano]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Pírez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rendimiento del GeneXpert en el diagnóstico de tuberculosis pulmonar y extrapulmonar en la edad pediátrica]]></article-title>
<source><![CDATA[Arch Pediatr Urug]]></source>
<year>2020</year>
<volume>91</volume>
<numero>^s2</numero>
<issue>^s2</issue>
<supplement>2</supplement>
<page-range>s12-23</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system for the diagnosis of pulmonary and extrapulmonary TB in adults and children. Policy update]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="book">
<collab>World Health Organization.Guidelines for treatment of drug-susceptible tuberculosis and patient care: 2017 update</collab>
<source><![CDATA[]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="confpro">
<source><![CDATA[VOT in the UK: results of a randomized control trial]]></source>
<year></year>
<conf-name><![CDATA[ Unión NAR Meeting]]></conf-name>
<conf-date>2017</conf-date>
<conf-loc>Vancouver, Canadá </conf-loc>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
